Abstract:Identification of high affinity drug-target interactions is a major research question in drug discovery. Proteins are generally represented by their structures or sequences. However, structures are available only for a small subset of biomolecules and sequence similarity is not always correlated with functional similarity. We propose ChemBoost, a chemical language based approach for affinity prediction using SMILES syntax. We hypothesize that SMILES is a codified language and ligands are documents composed of chemical words. These documents can be used to learn chemical word vectors that represent words in similar contexts with similar vectors. In ChemBoost, the ligands are represented via chemical word embeddings, while the proteins are represented through sequence-based features and/or chemical words of their ligands. Our aim is to process the patterns in SMILES as a language to predict protein-ligand affinity, even when we cannot infer the function from the sequence. We used eXtreme Gradient Boosting to predict protein-ligand affinities in KIBA and BindingDB data sets. ChemBoost was able to predict drug-target binding affinity as well as or better than state-of-the-art machine learning systems. When powered with ligand-centric representations, ChemBoost was more robust to the changes in protein sequence similarity and successfully captured the interactions between a protein and a ligand, even if the protein has low sequence similarity to the known targets of the ligand.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the accuracy of predicting protein - ligand binding affinity in drug - target interactions (DTI). Specifically, the authors propose a chemistry - language - based method, ChemBoost, which aims to represent ligands using SMILES syntax, so that it can effectively predict protein - ligand binding affinity even without protein structure information or with low sequence similarity. This method utilizes the string representation of chemical molecules (i.e., SMILES), regards it as a language, represents ligands by learning chemical word vectors, and combines the sequence features of proteins or the chemical words of their ligands to improve the performance of binding affinity prediction. The core contributions of the paper are as follows: 1. **Proposing a new representation method**: ChemBoost uses SMILES syntax as the basis of the chemical language, represents ligands by learning chemical word vectors, and explores multiple protein representation methods, including ligand - based representation methods. 2. **Improving prediction performance**: Through experiments on the KIBA and BindingDB datasets, ChemBoost has achieved or exceeded the performance of the existing state - of - the - art machine - learning systems in predicting protein - ligand binding affinity. 3. **Enhancing robustness to low sequence similarity**: ChemBoost is more robust when dealing with cases of low protein sequence similarity and can successfully capture the interactions between proteins and ligands, even when these proteins have low sequence similarity to known targets. In conclusion, this research provides a new computational tool for the identification of high - affinity drug - target interactions, a crucial step in drug discovery, and helps to accelerate the screening process of potential drug candidates.

ChemBoost: A chemical language based approach for protein-ligand binding affinity prediction

Exploring Data-Driven Chemical SMILES Tokenization Approaches to Identify Key Protein-Ligand Binding Moieties

Exploring Data‐Driven Chemical SMILES Tokenization Approaches to Identify Key Protein‐Ligand Binding Moieties

A Case-Based Meta-Learning Algorithm Boosts the Performance of Structure-Based Virtual Screening.

SimBoost: a read-across approach for predicting drug–target binding affinities using gradient boosting machines

Synergizing Chemical Structures and Bioassay Descriptions for Enhanced Molecular Property Prediction in Drug Discovery

Boosting: An Ensemble Learning Tool for Compound Classification and QSAR Modeling

Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis.

ALMERIA: Boosting pairwise molecular contrasts with scalable methods

Chemical Proteomics-based Target Prioritization through a Residue Agnostic Ligandability Assessment Platform

Boosting Protein-Ligand Binding Pose Prediction and Virtual Screening Based on Residue-Atom Distance Likelihood Potential and Graph Transformer

iScore: A ML-Based Scoring Function for Drug Discovery

iDTI-ESBoost: Identification of Drug Target Interaction Using Evolutionary and Structural Features with Boosting

High Performance of Gradient Boosting in Binding Affinity Prediction

DEELIG: A Deep Learning Approach to Predict Protein-Ligand Binding Affinity

DLSCORE: A Deep Learning Model for Predicting Protein-Ligand Binding Affinities

A machine learning approach to predicting protein–ligand binding affinity with applications to molecular docking

Learning Binding Affinities via Fine-tuning of Protein and Ligand Language Models

Ensembling machine learning models to boost molecular affinity prediction

CSM-lig: a web server for assessing and comparing protein–small molecule affinities

Machine Learning Scoring Functions for Drug Discoveries from Experimental and Computer-Generated Protein-Ligand Structures: Towards Per-Target Scoring Functions